Lv5
890 积分 2023-08-01 加入
Safety, Efficacy, and Pharmacokinetics of SHR-A1811, a Human Epidermal Growth Factor Receptor 2–Directed Antibody-Drug Conjugate, in Human Epidermal Growth Factor Receptor 2–Expressing or Mutated Advanced Solid Tumors: A Global Phase I Trial
2天前
已完结
Cardiotoxic Effects of Antibody Drug Conjugates vs Standard Chemotherapy in ERBB2-Positive Advanced Breast Cancer: A Systematic Review and Meta-Analysis
11天前
已完结
Cardiac toxicity of HER-2 targeting antibody–drug conjugates: overview and clinical implications
11天前
已完结
Novel antibody-drug conjugates based on DXd-ADC technology
1个月前
已完结
Novel antibody drug conjugates containing exatecan derivative-based cytotoxic payloads
1个月前
已完结
crVDAC3 alleviates ferroptosis by impeding HSPB1 ubiquitination and confers trastuzumab deruxtecan resistance in HER2-low breast cancer
1个月前
已完结
Payload Diversification Overcomes Resistance and Guides Sequential Antibody-Drug Conjugate Therapy in Breast Cancer
1个月前
已完结
Resistance Mechanisms and Post-Trastuzumab Deruxtecan (T-DXd) Strategies in HER2+ and HER2-Low Breast Cancer: From Biology to Clinical Practice
1个月前
已完结
Resistance Mechanisms and Post-Trastuzumab Deruxtecan (T-DXd) Strategies in HER2+ and HER2-Low Breast Cancer: From Biology to Clinical Practice
1个月前
已关闭
Alternative splicing generates HER2 isoform diversity underlying antibody–drug conjugate resistance in breast cancer
1个月前
已完结
皖公网安备34019202002308
